Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Biliary stent survey

This article was originally published in The Gray Sheet

Executive Summary

Polled interventional radiologists said they would increase their use of biliary stents if the devices received FDA approval for use in the peripheral vasculature, some by as much as 50%, according to a recent survey by the Millennium Research Group. Biliary stents are approved for use in bile ducts only, but are commonly used off label in peripheral arteries. "Physician attitudes toward off-label use of stents may provoke new manufacturer initiatives to obtain artery-specific FDA approval," says Millennium Research Group analyst Darren Navarro. "It might enable manufacturers to increase the price of their stents, growing revenues." The Department of Justice is conducting a civil investigation of allegations that Boston Scientific and other firms promoted biliary stents for off-label uses, Boston Scientific announced Feb. 28 in its annual report



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts